Sectors
HUMA
Humacyte, Inc.
0.74
4 x 0.73
15 x 0.74
bid
ask
-
0.01
0.87%
09:38 AM
timesize
| Ytd | -23.20% | |
| 1y | -57.83% |
0.73
day range
0.74
0.57
52 week range
2.48
| Open | 0.74 | Prev Close | 0.74 | Low | 0.73 | High | 0.74 | Mkt Cap | 122.61M |
| Vol | 377.95K | Avg Vol | 10.17M | EPS | -0.60 | P/E | -1.22 | Forward P/E | -5.41 |
| Beta | 2.53 | Short Ratio | 6.37 | Inst. Own | 30.01% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-10 | 50-d Avg | 0.86 | 200-d Avg | 1.02 | 1yr Est | 13.71 |
| Income Statement | |||
| Total Revenue | 495.00K | ||
| Revenues (USD) | 495.00K | ||
| Cost of Revenue | 2.04M | ||
| Gross Profit | -1.54M | ||
| Operating Expenses | 27.39M | ||
| Research and Development Expense | 19.46M | ||
| Selling, General and Administrative Expense | 7.93M | ||
| Operating Income | -28.93M | ||
| Interest Expense | 2.27M | ||
| Net Income | -17.62M | ||
| Net Income Common Stock | -17.62M | ||
| Net Income Common Stock (USD) | -17.62M | ||
| Consolidated Income | -17.62M | ||
| Earnings per Basic Share | -0.09 | ||
| Earnings per Basic Share (USD) | -0.09 | ||
| Earnings per Diluted Share | -0.09 | ||
| Earning Before Interest & Taxes (EBIT) | -15.35M | ||
| Earning Before Interest & Taxes (USD) | -15.35M | ||
| Weighted Average Shares | 197.85M | ||
| Weighted Average Shares Diluted | 197.85M | ||
| Balance Sheet | |||
| Cash and Equivalents | 48.75M | ||
| Cash and Equivalents (USD) | 48.75M | ||
| Trade and Non-Trade Receivables | 434.00K | ||
| Current Assets | 63.60M | ||
| Property, Plant & Equipment Net | 46.08M | ||
| Total Assets | 110.56M | ||
| Debt Current | 2.43M | ||
| Total Debt | 65.90M | ||
| Current Liabilities | 16.19M | ||
| Debt Non-Current | 63.47M | ||
| Total Liabilities | 98.93M | ||
| Accumulated Retained Earnings (Deficit) | -744.47M | ||
| Shareholders Equity | 11.62M | ||
| Shareholders Equity (USD) | 11.62M | ||
| Assets Non-Current | 46.96M | ||
| Total Debt (USD) | 65.90M | ||
| Inventory | 9.92M | ||
| Liabilities Non-Current | 82.75M | ||
| Trade and Non-Trade Payables | 5.08M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.79M | ||
| Net Cash Flow from Financing | 23.32M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.96M | ||
| Capital Expenditure | -175.00K | ||
| Issuance (Purchase) of Equity Shares | 23.32M | ||
| Net Cash Flow from Investing | -175.00K | ||
| Net Cash Flow from Operations | -25.10M | ||
| Share Based Compensation | 3.17M | ||